InvestorsHub Logo

H2R

Followers 42
Posts 2163
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: TC_Trader post# 93937

Tuesday, 01/10/2017 10:22:27 AM

Tuesday, January 10, 2017 10:22:27 AM

Post# of 693944
I really like L + PD-1 in the combo trial

A Phase II Clinical Trial Evaluating Combination Therapy Using DCVax-L (Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen) and Nivolumab (an Anti-PD-1 Antibody) for Subjects With Recurrent Glioblastoma Multiforme



This looks like a key trial in I/O! It could have a chance of becoming the SOC, especially if safety is as good as with L.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News